These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 12975161

  • 1. The safety and efficacy of tacrolimus therapy in patients younger than 2 years with atopic dermatitis.
    Patel RR, Vander Straten MR, Korman NJ.
    Arch Dermatol; 2003 Sep; 139(9):1184-6. PubMed ID: 12975161
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: results from a randomized, double-blind, vehicle-controlled study.
    Schachner LA, Lamerson C, Sheehan MP, Boguniewicz M, Mosser J, Raimer S, Shull T, Jaracz E, US Tacrolimus Ointment Study Group.
    Pediatrics; 2005 Sep; 116(3):e334-42. PubMed ID: 16140675
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis.
    Reitamo S, Ortonne JP, Sand C, Cambazard F, Bieber T, Fölster-Holst R, Vena G, Bos JD, Fabbri P, Groenhoej Larsen C, European Tacrolimus Ointment Study Group.
    Br J Dermatol; 2005 Jun; 152(6):1282-9. PubMed ID: 15948994
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparing tacrolimus ointment and oral cyclosporine in adult patients affected by atopic dermatitis: a randomized study.
    Pacor ML, Di Lorenzo G, Martinelli N, Mansueto P, Rini GB, Corrocher R.
    Clin Exp Allergy; 2004 Apr; 34(4):639-45. PubMed ID: 15080819
    [Abstract] [Full Text] [Related]

  • 9. The safety and efficacy of tacrolimus ointment in pediatric patients with atopic dermatitis.
    McCollum AD, Paik A, Eichenfield LF.
    Pediatr Dermatol; 2010 Apr; 27(5):425-36. PubMed ID: 20678096
    [Abstract] [Full Text] [Related]

  • 10. Non-melanoma skin cancer in patients with atopic dermatitis treated with topical tacrolimus.
    Naylor M, Elmets C, Jaracz E, Rico JM.
    J Dermatolog Treat; 2005 Aug; 16(3):149-53. PubMed ID: 16096180
    [Abstract] [Full Text] [Related]

  • 11. The pharmacokinetics of tacrolimus after first and repeated dosing with 0.03% ointment in infants with atopic dermatitis.
    Reitamo S, Mandelin J, Rubins A, Remitz A, Mäkelä M, Cirule K, Rubins S, Zigure S, Ho V, Dickinson J, Undre N.
    Int J Dermatol; 2009 Apr; 48(4):348-55. PubMed ID: 19335418
    [Abstract] [Full Text] [Related]

  • 12. Investigation on the clinical efficacy and safety of 0.1% tacrolimus ointment (Protopic) in canine atopic dermatitis: a randomized, double-blinded, placebo-controlled, cross-over study.
    Marsella R, Nicklin CF, Saglio S, Lopez J.
    Vet Dermatol; 2004 Oct; 15(5):294-303. PubMed ID: 15500481
    [Abstract] [Full Text] [Related]

  • 13. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.
    Kubota Y, Yoneda K, Nakai K, Katsuura J, Moriue T, Matsuoka Y, Miyamoto I, Ohya Y.
    J Am Acad Dermatol; 2009 Feb; 60(2):212-7. PubMed ID: 19027990
    [Abstract] [Full Text] [Related]

  • 14. The safety of tacrolimus ointment for the treatment of atopic dermatitis: a review.
    Rustin MH.
    Br J Dermatol; 2007 Nov; 157(5):861-73. PubMed ID: 17854353
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of tacrolimus ointment treatment for up to 4 years in patients with atopic dermatitis.
    Hanifin JM, Paller AS, Eichenfield L, Clark RA, Korman N, Weinstein G, Caro I, Jaracz E, Rico MJ, US Tacrolimus Ointment Study Group.
    J Am Acad Dermatol; 2005 Aug; 53(2 Suppl 2):S186-94. PubMed ID: 16021174
    [Abstract] [Full Text] [Related]

  • 16. Atopic dermatitis management with tacrolimus ointment (Protopic).
    Kapp A, Allen BR, Reitamo S.
    J Dermatolog Treat; 2003 Aug; 14(Suppl 1):5-16. PubMed ID: 14522634
    [Abstract] [Full Text] [Related]

  • 17. Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment.
    Wollenberg A, Reitamo S, Girolomoni G, Lahfa M, Ruzicka T, Healy E, Giannetti A, Bieber T, Vyas J, Deleuran M, European Tacrolimus Ointment Study Group.
    Allergy; 2008 Jul; 63(7):742-50. PubMed ID: 18592619
    [Abstract] [Full Text] [Related]

  • 18. Tacrolimus ointment (Protopic) for atopic dermatitis.
    Pascual JC, Fleisher AB.
    Skin Therapy Lett; 2004 Nov; 9(9):1-5. PubMed ID: 15550992
    [Abstract] [Full Text] [Related]

  • 19. Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment.
    Wollenberg A, Reitamo S, Atzori F, Lahfa M, Ruzicka T, Healy E, Giannetti A, Bieber T, Vyas J, Deleuran M, European Tacrolimus Ointment Study Group.
    Allergy; 2008 Jun; 63(6):742-50. PubMed ID: 18445188
    [Abstract] [Full Text] [Related]

  • 20. Superiority of tacrolimus 0.1% ointment compared with fluticasone 0.005% in adults with moderate to severe atopic dermatitis of the face: results from a randomized, double-blind trial.
    Doss N, Reitamo S, Dubertret L, Fekete GL, Kamoun MR, Lahfa M, Ortonne JP.
    Br J Dermatol; 2009 Aug; 161(2):427-34. PubMed ID: 19416227
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.